These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24414120)
1. The current state of stem cell therapy for peripheral artery disease. Gupta NK; Armstrong EJ; Parikh SA Curr Cardiol Rep; 2014 Feb; 16(2):447. PubMed ID: 24414120 [TBL] [Abstract][Full Text] [Related]
2. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477 [TBL] [Abstract][Full Text] [Related]
3. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products. Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820 [TBL] [Abstract][Full Text] [Related]
4. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia]. Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676 [TBL] [Abstract][Full Text] [Related]
5. A long-term outcome of therapeutic angiogenesis by transplantation of peripheral blood stem cells in critical limb ischemia after interventional revascularization. Reddy AM; Kwak BK; Shim HJ; Jang EC; Park AJ; Park E; Ahn C Diagn Interv Radiol; 2013; 19(1):76-80. PubMed ID: 23019056 [TBL] [Abstract][Full Text] [Related]
6. Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study. Das AK; Bin Abdullah BJ; Dhillon SS; Vijanari A; Anoop CH; Gupta PK World J Surg; 2013 Apr; 37(4):915-22. PubMed ID: 23307180 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic cellular angiogenesis in treatment of peripheral artery diseases]. Khorev NG; Elykomov VA; Zaloznyĭ DA Angiol Sosud Khir; 2011; 17(2):36-44. PubMed ID: 21983460 [TBL] [Abstract][Full Text] [Related]
10. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia. Beltrán-Camacho L; Rojas-Torres M; Durán-Ruiz MC Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652743 [TBL] [Abstract][Full Text] [Related]
12. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials. Lakshmanan R; Ukani G; Rishi MT; Maulik N Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473 [TBL] [Abstract][Full Text] [Related]
13. Current Phase II drugs under investigation for the treatment of limb ischemia. Spiliopoulos S; Kitrou P; Katsanos K; Karnabatidis D Expert Opin Investig Drugs; 2015; 24(11):1447-58. PubMed ID: 26296189 [TBL] [Abstract][Full Text] [Related]
18. Adult stem cells and the clinical arena: are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization? Casamassimi A; Grimaldi V; Infante T; Al-Omran M; Crudele V; Napoli C Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):99-108. PubMed ID: 22352682 [TBL] [Abstract][Full Text] [Related]
19. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092 [TBL] [Abstract][Full Text] [Related]
20. Stem cell therapy in end-stage cardiovascular disease: the final nail in the coffin or still some light at the end of the tunnel? Reinecke H; Reinecke H; Reinecke H; Reinecke H Vasa; 2016; 45(3):260. PubMed ID: 27129074 [No Abstract] [Full Text] [Related] [Next] [New Search]